2. NF-κB
  3. Keap1-Nrf2
  4. Keap1-Nrf2-IN-28

Keap1-Nrf2-IN-28 (SG16) is an orally active Keap1-Nrf2 inhibitor. Keap1-Nrf2-IN-28 shows antioxidant capability and induces the upregulation of Nrf2, HO-1, GCLM, and Akr1c1. Keap1-Nrf2-IN-28 attenuates APAP (HY-66005)-induced acute liver injury.

For research use only. We do not sell to patients.

Keap1-Nrf2-IN-28 Chemical Structure

Keap1-Nrf2-IN-28 Chemical Structure

CAS No. : 3075750-60-3

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Keap1-Nrf2-IN-28 Related Antibodies

Top Publications Citing Use of Products

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Keap1-Nrf2-IN-28 (SG16) is an orally active Keap1-Nrf2 inhibitor. Keap1-Nrf2-IN-28 shows antioxidant capability and induces the upregulation of Nrf2, HO-1, GCLM, and Akr1c1. Keap1-Nrf2-IN-28 attenuates APAP (HY-66005)-induced acute liver injury[1].

In Vitro

Keap1-Nrf2-IN-28 (Compound SG16) (10 μM, 16 h) induces a remarkable 10.7-fold increase in HO-1 expression in AML12 cells, indicating the Nrf2 induction activity[1].
Keap1-Nrf2-IN-28 (0-10 μM, 16 h) upregulates HO-1, GCLM, and Akr1c1 mRNA expression and protein expression of Nrf2, HO-1 and GCLM in AML12 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Keap1-Nrf2-IN-28 Related Antibodies

RT-PCR[1]

Cell Line: AML12 cells
Concentration: 0.5, 2.5, 5, 10 μM
Incubation Time: 16 h
Result: Induced significant upregulation of HO-1, GCLM, and Akr1c1 expression by 3.4-, 2.3-, and 1.8-fold at 10 μM, respectively.
Dose-dependently increased mRNA level of HO-1, GCLM and Akr1c1.
Parmacokinetics[1]
Species Dose Route Indicator value
Rat 1 mg/kg i.v. AUC0-inf 4726 ng·h/mL
Rat 10 mg/kg p.o. AUC0-inf 8061 ng·h/mL
Rat 1 mg/kg i.v. AUC0-t 3869 ng·h/mL
Rat 10 mg/kg p.o. AUC0-t 7689 ng·h/mL
Rat 1 mg/kg i.v. Cmax 1050 ng/mL
Rat 10 mg/kg p.o. Cmax 1296 ng/mL
Rat 1 mg/kg i.v. T1/2 5.45 hr
Rat 10 mg/kg p.o. T1/2 3.47 hr
Rat 1 mg/kg i.v. Tmax 0.17 hr
Rat 10 mg/kg p.o. Tmax 1.50 hr
Rat 1 mg/kg i.v. CL 20 mL/min/kg
In Vivo

Keap1-Nrf2-IN-28 (Compound SG16) (12.5 or 25 mg/kg, i.p.) protects mouse from APAP (HY-66005)-induced acute liver injury (ALI)[1].
Keap1-Nrf2-IN-28 (25 mg/kg, i.p.) has no liver protection in Nrf2 knockout mice[1].
Keap1-Nrf2-IN-28 (25 mg/kg, i.p.) shows favorable biocompatibility without inducing detectable organ toxicity C57BL/6J mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: APAP (370 mg/kg, i.p.)-induced acute liver injury (ALI) C57BL/6 mice model[1]
Dosage: 12.5 or 25 mg/kg
Administration: i.p., 1 h following APAP injection, and then samples were collected 12 h later.
Result: Increased both GCLM and HO-1 (100-fold at a dose of 25 mg/kg) mRNA levels in liver tissue than those of negative control (NC) group.
Promoted the nuclear translocation of Nrf2 in liver tissue.
Disrupted the binding between Keap1 and Nrf2 (Co-IP assay).
Significantly reduced ALT/AST levels and attenuated the APAP-conducted elevation of CAT and NO concentrations.
Decreased pathological damage and cell apoptosis in HE staining and TUNEL test.
Lowered liver IL-6 and TNFα levels increased by APAP.
Molecular Weight

425.43

Formula

C22H16FNO5S
CAS No.
SMILES

O=S(C1=CC=C(F)C=C1)(NC2=CC3=C(C=C2)C(C=C(C4=CC=C(OC)C=C4)O3)=O)=O
Shipping

Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.

Keap1-Nrf2-IN-28 Related Classifications

  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Keywords:

Keap1-Nrf2-IN-283075750-60-3Keap1-Nrf2AML12 cellsAPAP-induced ALI In vivoInhibitorinhibitorinhibit

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

  

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

      

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Keap1-Nrf2-IN-28
Cat. No.:
HY-172598
Quantity:
MCE Japan Authorized Agent:

Customer Review

Thank You for Your Feedback!

Request for HNMR Report

Please fill out this form to request the QC report. We will send it to your Email address shortly.

Your information is safe with us. * Required Fields.

Product Name

  

Lot #

Applicant Name *

 

Email Address *

Phone Number

 

Department *

Organization Name *

 

Country or Region *

Remarks

SAFETY DATA SHEET (SDS)

English - EN (0 KB) Français - FR (0 KB) Deutsch - DE (0 KB) Norwegian - NO (0 KB) Español - ES (0 KB) Swedish - SV (0 KB) Italian - IT (0 KB) Portuguese - PT (0 KB)

Request for HNMR Report

We have received your request and will respond to you as soon as possible.